Table 3.
The correlation of circ0001791 expression levels and clinicopathological features of the BC patients. P < 0.05 was considered statistically significant.
| hsa_circ_0001791 | ||||
|---|---|---|---|---|
| Feature | NO:60 | Low | High | P value |
| Age | ||||
| ≤50 | 28 | 18 | 20 | 0.75 |
| >50 | 22 | 12 | 10 | |
|
| ||||
| Family history | ||||
| Yes | 30 | 15 | 15 | 0.2 |
| No | 30 | 14 | 16 | |
|
| ||||
| TNM staging | ||||
| I-II | 27 | 18 | 15 | 0.2 |
| III-IV | 33 | 17 | 10 | |
|
| ||||
| Depth of invasion | ||||
| T1-T2 | 29 | 13 | 16 | 0.4 |
| T3-T4 | 31 | 14 | 17 | |
|
| ||||
| Lymphoid node infiltrated | ||||
| Yes | 33 | 17 | 16 | 0.31 |
| No | 27 | 10 | 17 | |
|
| ||||
| PR+ | 22 | 8 | 14 | 0.551 |
| PR− | 38 | 18 | 20 | |
|
| ||||
| ER+ | 33 | 24 | 9 | 0.0306∗ |
| ER− | 27 | 16 | 11 | |
|
| ||||
| HER2+ | 31 | 15 | 16 | 0.3 |
| HER2− | 29 | 11 | 18 | |